Can a Daily Multivitamin Actually Slow Biological Aging? What New Research Shows
For years, multivitamins have been dismissed by critics as little more than “nutritional insurance,” a simple backup plan for days when the diet is less than perfect. That phrase is not entirely wrong, but it may be too small. Emerging research suggests that the role of a broad-spectrum multivitamin may extend far beyond filling obvious nutrient gaps. A new study published in Nature Medicine in March 2026 raises a more profound question: what if consistent daily intake of essential vitamins and minerals can influence the rate at which the body biologically ages? [1]
That is the question researchers explored in a major ancillary study from the COSMOS trial, a large randomized clinical trial that examined whether daily multivitamin–multimineral supplementation or cocoa extract could affect measurable biological aging in older adults. The results were modest, but important. Over two years, the multivitamin group showed a statistically significant slowing in two of the most clinically relevant epigenetic aging clocks, while cocoa extract did not show the same benefit.
To understand why this matters, it helps to first understand what the researchers were actually measuring.
What Is “Biological Aging”?
Chronological age is simply how many years have passed since a person was born. Biological age is different. It refers to how “old” the body appears to be functioning at the cellular and molecular level. Two people can both be 70 years old on paper, but one may have a body that functions more like a younger person while the other may show signs of faster decline.
One of the most promising ways scientists estimate biological age is by studying DNA methylation, a pattern of chemical tags that attach to DNA and help regulate which genes are turned on or off. These patterns shift over time and can be used to generate what are known as epigenetic clocks. In simpler terms, epigenetic clocks are laboratory tools that estimate how fast the body is aging by reading aging-related changes written into the genome’s regulatory markings.
These clocks matter because they do not just correlate with birthday candles. Some of them are strongly associated with disease risk, mortality, and the pace of physiological decline. That is why a trial showing even a modest change in these measures attracts so much attention.
How the Study Was Designed
This was not a small pilot trial. The parent COSMOS study originally enrolled 21,442 adults, including women aged 65 and older and men aged 60 and older. The epigenetic aging analysis came from a blood-based ancillary study nested within COSMOS. Researchers selected 958 participants who had usable DNA methylation data at baseline and at least one follow-up measurement, and they tracked changes over a two-year period. The average age was about 70.2 years, and just over half the participants were women.
Participants were randomized to receive either an active multivitamin or placebo, and separately randomized to cocoa extract or placebo. Compliance was high, with more than 91% adherence for the multivitamin arm and more than 95% adherence for the cocoa arm when defined as taking more than 75% of study pills without outside supplements. That is important because it strengthens confidence that the observed effects were related to the intervention itself rather than inconsistent use.
The investigators focused on five epigenetic measures: Horvath, Hannum, PhenoAge, GrimAge, and DunedinPACE. The first two clocks are older “first-generation” clocks that mainly track chronological age. PhenoAge and GrimAge are newer “second-generation” clocks built to better reflect health risk and mortality. DunedinPACE estimates the pace at which aging is occurring rather than simply assigning an age. In plain language, some clocks ask, “How old does this body look?” while others ask, “How quickly is this body wearing down?”
What the Researchers Found
The multivitamin did not significantly change every clock, but it did meaningfully affect two of the most important ones: PCPhenoAge and PCGrimAge. Compared with placebo, the multivitamin group showed a slower yearly increase in these aging markers. The between-group difference in yearly change was −0.214 years for PCPhenoAge and −0.113 years for PCGrimAge, both statistically significant. In other words, the multivitamin group aged more slowly on these measures over the two-year period.
At the two-year mark, the change from baseline was also significantly smaller in the multivitamin group for both clocks. DunedinPACE showed a favorable direction as well, remaining more stable in the multivitamin group while increasing in the placebo group, but that result did not reach statistical significance. The older Horvath and Hannum clocks also did not show significant differences.
This selective pattern is actually scientifically interesting. The clocks that changed were the ones designed to better capture disease-related aging and mortality risk, not merely the passage of time. That means the intervention may have influenced aspects of aging that are biologically meaningful rather than just shifting a superficial age estimate. The authors themselves emphasize that PhenoAge and GrimAge tend to be more responsive and more closely linked to major morbidity and mortality than the older clocks.
How Big Was the Effect?
The effect was not dramatic, and the researchers were careful not to overstate it. The study describes the changes as small but statistically significant. Still, in aging science, “small” does not automatically mean trivial. The authors explain that the observed slowing corresponded to roughly 2.7 to 5.1 months less biological aging after two years, depending on the clock used.
That may sound modest, but the body does not age in giant leaps. Aging is a cumulative process driven by millions of small changes in nutrient status, inflammation, oxidative stress, cellular signaling, DNA maintenance, mitochondrial function, and tissue repair. A daily intervention that nudges several of those systems in a healthier direction, consistently, for years, may have meaningful long-term consequences.
The paper also notes that based on prior associations reported for these clocks, the observed effect size could correspond to a lower long-term risk of age-related outcomes such as cancer. The authors are cautious here, and rightly so, because this trial was not designed to prove that epigenetic changes directly caused better outcomes. But the result fits with previous COSMOS findings showing benefits of multivitamin supplementation for cognition and with prior randomized trial data suggesting benefits for some aging-related conditions.
Who Benefited the Most?
One of the most interesting findings was that people who appeared to be aging faster at baseline often benefited more. Participants who began the trial with accelerated biological aging—meaning their biological age looked older than their chronological age on certain clocks—showed stronger responses to the multivitamin. For PCGrimAge, those with accelerated aging at baseline had a significant reduction in the rate of increase, whereas those with more normal or slower aging at baseline did not show the same effect. Similar patterns were seen for PCPhenoAge and DunedinPACE, though not every subgroup interaction reached formal statistical significance.
This makes biological sense. A person with greater nutritional strain, more oxidative burden, or more accumulated physiological wear may simply have more room to improve. The paper also reports post-hoc evidence suggesting that lower nutritional biomarker levels were associated with accelerated biological aging at baseline, and that larger improvements in nutritional biomarkers tended to track with more favorable changes in epigenetic aging during follow-up.
That is an important point. It suggests that part of what these clocks are picking up may be the body’s response to nutrient sufficiency or insufficiency.
Why Might a Multivitamin Affect Aging at All?
Aging is not caused by one single deficiency. It is a network problem. Cells require a constant supply of vitamins, minerals, and co-factors to produce energy, repair DNA, maintain antioxidant defenses, regulate methylation, balance inflammation, support neurotransmitter production, and preserve tissue function.
B vitamins, for example, help drive methylation and energy metabolism. Vitamin C supports antioxidant recycling and collagen biology. Vitamin D affects immune and gene-regulatory signaling. Magnesium acts as a cofactor in hundreds of enzymatic reactions. Zinc, selenium, copper, and manganese support antioxidant enzymes and tissue maintenance. Vitamins A and E help protect membranes and regulate cellular differentiation. When intake is inconsistent or marginal across several of these nutrients at once, the body may still function, but it may function less efficiently and with less resilience over time.
The paper points out that global inadequacy of micronutrient intake remains widespread and that more than five billion people may not consume enough essential micronutrients from food, especially nutrients such as iodine, vitamin E, and calcium. It also notes that multivitamins are widely used precisely because they provide a broad combination of essential vitamins and minerals that can help reduce the risk of insufficiency.
In that context, a multivitamin is not simply “extra.” It may be a way of ensuring that multiple aging-relevant biochemical systems are not being slowed down by quiet, chronic shortfalls.
What Are the Practical Implications?
This study does not prove that every person who takes a multivitamin will suddenly age slower in an obvious, visible way. It also does not prove that every multivitamin formula is equal. What it does show is that comprehensive daily micronutrient support can produce measurable changes in two validated markers of biological aging in older adults over time.
That matters because it supports a more sophisticated view of supplementation. The body does not run on calories alone. It runs on nutrients. And because biological aging is shaped by cumulative cellular stress, subtle insufficiencies across many nutrients may matter more than people realize.
A thoughtfully designed multivitamin is one of the few interventions that addresses many of those variables at once.
Why the Three Ultimate Multiple Formulas Fit This Research
The three Healthmasters formulas you shared all reflect the main lesson of the COSMOS study: broad nutritional coverage matters.
Healthmasters' Ultimate Multiple Capsules provide a concentrated foundational formula with meaningful amounts of vitamin A, vitamin C, vitamin E, thiamin, riboflavin, niacin, vitamin B6, folate, vitamin B12, biotin, pantothenic acid, iodine, magnesium, zinc, selenium, copper, manganese, chromium, molybdenum, and supportive compounds like inositol and PABA. The use of methylfolate and methylcobalamin is notable because these are readily usable forms involved in methylation-related pathways, which is especially relevant in light of a study centered on DNA methylation aging clocks. The formula also includes chelated minerals for improved absorption and provides a strong dose of vitamin E and B-complex support, both important for antioxidant defense and metabolic function.
Healthmasters' Ultimate Multiple Powder expands that foundation into a more comprehensive daily drink format. It contains higher vitamin C, substantial vitamin E, methylfolate, methylcobalamin, magnesium, zinc, selenium, boron, vitamin K2, mixed tocopherols, lemon bioflavonoids, natural mixed carotenoids, and other supportive compounds. This is the kind of broad-spectrum nutritional approach that fits the logic of the COSMOS paper very well. When researchers talk about multivitamins supporting several biological systems at once, this is the sort of formula they have in mind: not a single isolated nutrient, but a coordinated nutritional matrix.
Finally, Healthmasters' Ultimate Multiple Chewable offers many of the same essentials in a more approachable format, including vitamins A, C, D3, E, B-complex nutrients, methylfolate, methylcobalamin, zinc, selenium, chromium, vitamin K2, mixed tocopherols, and natural carotenoids. For someone who prefers chewables or wants a simpler route to consistency, this formula still captures the core principle of the study: daily, broad, reliable intake of multiple essential nutrients.
Each of these formulas differs in delivery and emphasis, but all three are built around the same central idea supported by the new research: long-term health is not sustained by one “miracle” ingredient. It is sustained by making sure the body has the raw materials it needs every day.
Conclusion
The new COSMOS epigenetic aging study adds real weight to the case for comprehensive multivitamin supplementation. In a large randomized clinical trial, daily multivitamin use modestly but significantly slowed two key biological aging clocks over two years, especially in people who appeared biologically older at baseline.
The message is not that a multivitamin replaces sleep, exercise, protein, sunlight, or a healthy diet. It is that the body’s aging process is influenced by whether it has enough of the essential micronutrients required for repair, protection, signaling, and energy production. When those needs are met more consistently, the biology of aging itself may shift in a more favorable direction.
That is why a strong daily foundation still matters. And it is why a broad-spectrum formula like Ultimate Multiple Capsules, Ultimate Multiple Powder, or Ultimate Multiple Chewable makes sense not just as convenience, but as an investment in better long-term nutritional support.
References
[1] Wang, Y., Sesso, H. D., Vyas, C. M., Kwee, L. C., Kurniansyah, N., Selhub, J., Brickman, A. M., Schernhammer, E. S., Manson, J. E., & collaborators. (2026). Effects of daily multivitamin–multimineral and cocoa extract supplementation on epigenetic aging clocks in the COSMOS randomized clinical trial. Nature Medicine. https://doi.org/10.1038/s41591-026-04239-3.
*The matters discussed in this article are for informational purposes only and not medical advice. Please consult your healthcare practitioner on the matters discussed herein.
*These statements have not been evaluated by the Food and Drug Administration. Healthmasters' products are not intended to diagnose, treat, cure, or prevent any disease.